{"text": "biib sage share update on fda advisory committee for zuranolone fda does not currently plan to convene an adcomm meeting to discuss the nda for zuranolone"}
{"text": "sage 1 2 pre biib biogen and sage therapeutics share update on fda advisory committee for zuranolone ir"}
{"text": "amazing how fast biib tysabri and rhhby ocrevus got to 1b in sales good chance tgtx does the same since it s safer cheaper and more convenient"}
{"text": "no adcom for zur i was undecided whether they end up in an adcom mainly for safety new treatment paradigm type of descn efficacy side likely ok in the context of these drugs pdac is somewhat unpredictable but lean ve in the neuro adcom folks biib sage"}
{"text": "sage therapeutics and biogen biib share update on fda advisory committee for zuranolone no adcom pdufa date august 5th"}
{"text": "biotech stock news 3 8 23 am tlsa 9 foralumab publications illustrates moa opk 7 exclusive ww license w mrk sage 6 no adcomm for zuralone cc biib avir 2 data to be presented for covid hep c jazz 1 8 additional reimbursements for vyxeos ltrn 0 to host kol on"}
